News

Scientists from The University of Texas at Austin took an important step toward safer gene-editing cures for life-threatening disorders, from cancer to HIV to Huntington's disease, by developing a technique that can spot editing mistakes a popular tool known as CRISPR makes to an individual's genome. The research appears today in the journal Cell.

About a third of all deaths in the U.S. could be prevented or substantially delayed by organ transplantation, according to a 2015 report from the U.S. military. The main bottleneck is that there is no practical way to preserve organs for more than a few hours. If you try to freeze a whole organ, water within and between cells forms ice crystals that cause the cells to rupture.

The number of hours an obstetrician has been on the clock before an unscheduled delivery significantly influences risks to the mother and unborn baby, researchers report.

Chemists at The University of Texas at Austin have developed a material that holds the key to cheap, fast and portable new sensors for a wide range of chemicals that right now cost government and industries large sums to detect. The innovation could lead to major public health gains, as it holds the potential to drastically reduce the costs associated with cleaning-up accidental chemical spills, remediating old industrial sites, detecting radioactive contamination in drinking water, and operating medical and research imaging devices.

It's been called the most complicated object in the known universe. But, as UT scientists are learning, the human brain offers five important clues for understanding its wonders.

Women in Natural Sciences, a small learning community within the College, has been raising retention rates in science and the academic success rates of its students for years. Now it's looking to the community to help raise support and capacity in the program.

A profile of UT Austin chemist and professor Jonathan Sessler is inspiring scientists to share their stories about what drives them in their work.

George Georgiou, a professor of engineering and molecular biosciences at the University of Texas at Austin, and his colleagues have developed a hybrid antibody that neutralized 99 percent of HIV-1 strains tested. The antibody is based on so-called "broadly-neutralizing antibodies," a group of antibodies from HIV-infected patients that are able to take down an array of rapidly mutating HIV-1 viruses.

The National Institutes of Health has awarded an international consortium seeking better pharmaceutical treatments for alcoholism a five-year grant totaling $29 million. The administrative headquarters and several of the projects will be at The University of Texas at Austin, which will receive $8.5 million of the total.

People with cystic fibrosis, diabetes, and chronic obstructive pulmonary disease often develop serious and even life-threatening bacterial infections that are hard to treat, in large part because the bacteria form dense clusters called biofilms. Biofilms are resistant to the host's immune cells and to antibiotics.